Dermata Therapeutics, Inc. (DRMA)

NASDAQ: DRMA · IEX Real-Time Price · USD

3.835

+0.315 (8.95%)

At close: May 31, 2024, 3:59 PM

3.670

-0.165 (-4.30%)

After-hours: May 31, 2024, 7:46 PM EDT

Dermata Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-7.79	-9.61	-10.46	-3.24	-4.72
Depreciation & Amortization	0	0	0	0	0
Share-Based Compensation	0.52	0.93	1.91	0	0
Other Operating Activities	0.86	-0.15	0.3	-0.79	0.8
Operating Cash Flow	-6.41	-8.83	-5.69	-4.03	-3.92
Share Issuance / Repurchase	7.61	4.28	15.39	0	0
Debt Issued / Paid	0	0	1.01	2.3	-0.63
Other Financing Activities	0	0	-0.43	0.27	5.36
Financing Cash Flow	7.61	4.28	15.96	2.57	4.73
Net Cash Flow	1.2	-4.56	10.27	-1.46	0.81
Free Cash Flow	-6.41	-8.83	-5.69	-4.03	-3.92
Free Cash Flow Per Share	-32.87	-191.86	-317.61	-505.94	-492.59

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).